Brief: Quoin Pharmaceuticals Approves ADS Ratio Change To 120
04/04/2025 13:46
April 4 (Reuters) - Quoin Pharmaceuticals Ltd 2EBy.BE: QUOIN PHARMACEUTICALS LTD - APPROVES ADS RATIO CHANGE TO 1:20 - SEC FILING Source text: [ID:n0001104659-25-032004] Further company coverage: [2EBy.BE] (((( Reuters.briefs@thomsonreuters.com ;));))
Recent news on Quoin Pharmaceuticals
See all newsQuoin Pharmaceuticals Ltd reports results for the quarter ended June 30 - Earnings Summary
Quoin Pharmaceuticals Ltd expected to post a loss of $1.61 a share - Earnings Preview
Quoin Pharmaceuticals Ltd expected to post a loss of $1.61 a share - Earnings Preview
NASDAQ RESUMED AT 10:15 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:06 AM